Yedlapudi, D., Xu, L., Luo, D., Marsh, G. B., Todi, S. V., & Dutta, A. K. (2019). Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia. Nature Portfolio.
Cita Chicago Style (17a ed.)Yedlapudi, Deepthi, Liping Xu, Dan Luo, Gregory B. Marsh, Sokol V. Todi, y Aloke K. Dutta. Targeting Alpha Synuclein and Amyloid Beta by a Multifunctional, Brain-penetrant Dopamine D2/D3 Agonist D-520: Potential Therapeutic Application in Parkinson’s Disease with Dementia. Nature Portfolio, 2019.
Cita MLA (8a ed.)Yedlapudi, Deepthi, et al. Targeting Alpha Synuclein and Amyloid Beta by a Multifunctional, Brain-penetrant Dopamine D2/D3 Agonist D-520: Potential Therapeutic Application in Parkinson’s Disease with Dementia. Nature Portfolio, 2019.